Douglas C. Throckmorton
- Pharmacology top 1%
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 2
- Toxicology top 5%
- Clinical Biochemistry top 5%
-
- Opioid Use Disorder Treatment 6
-
- Protein Kinase Regulation and GTPase Signaling 3
-
- Cardiac electrophysiology and arrhythmias 3
-
- Pharmaceutical Practices and Patient Outcomes 3
-
- Nitric Oxide and Endothelin Effects 2
-
- Substance Abuse Treatment and Outcomes 2
-
- Meta-analysis and systematic reviews 2
- Co-authors
- S-M HuangLawrence J. LeskoR TempleHoward RasmussenMichael KashgarianPeter LurieChristopher M. JonesRobert W. Wrenn
- Cited by
- PharmacologyNephrologyToxicology
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Douglas C. Throckmorton
28 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 124
- Pharmacology 310
- Nephrology 143
- Toxicology 58
- Anesthesiology and Pain Medicine 92
- Clinical Biochemistry 88
Countries citing papers authored by Douglas C. Throckmorton
This map shows the geographic impact of Douglas C. Throckmorton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas C. Throckmorton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas C. Throckmorton more than expected).
Fields of papers citing papers by Douglas C. Throckmorton
This network shows the impact of papers produced by Douglas C. Throckmorton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas C. Throckmorton. The network helps show where Douglas C. Throckmorton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas C. Throckmorton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 47 | |
| 2 | 2018 | 40 | |
| 3 | 2018 | 50 | |
| 4 | 2018 | 2 | |
| 5 | 2016 | 108 | |
| 6 | 2015 | 1 | |
| 7 | 2015 | 14 | |
| 8 | 2012 | 37 | |
| 9 | 2011 | 77 | |
| 10 | 2011 | 1 | |
| 11 | 2008 | 14 | |
| 12 | 2007 | 469 | |
| 13 | 2004 | 13 | |
| 14 | 1998 | 34 | |
| 15 | 1997 | 47 | |
| 16 | 1996 | 5 | |
| 17 | 1995 | 101 | |
| 18 | 1995 | 156 | |
| 19 | 1995 | 49 | |
| 20 | 1995 | 146 |
About Douglas C. Throckmorton
Douglas C. Throckmorton is a scholar working on Toxicology, Geriatrics and Gerontology and Clinical Biochemistry, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (6 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Substance Abuse Treatment and Outcomes (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Meta-analysis and systematic reviews (2 papers). The work is most often cited by research in Pharmacology (310 citations), Nephrology (143 citations) and Toxicology (58 citations). Douglas C. Throckmorton has collaborated with scholars based in United States and Japan. Frequent co-authors include S-M Huang, Lawrence J. Lesko, R Temple, Howard Rasmussen, Michael Kashgarian, Peter Lurie, Christopher M. Jones, Robert W. Wrenn, Dongli Song and David H. Munn. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.